Profusa (NVACW) Equity Ratio (2021 - 2026)
Profusa posted quarterly Equity Ratio of 32.71 for Q1 2026, up 46.78% year-on-year from 22.29 in Q1 2025, and down 363.23% on a QoQ basis from 7.06 in Q4 2025.
Profusa (NVACW) has 6 years of Equity Ratio data on file, last reported at 32.71 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 46.78% year-over-year to 32.71; the trailing twelve-month figure through Mar 2026 stood at 32.71 (up 46.78% YoY), and the FY2025 full-year result was 7.06, up 81.8% from the prior year.
- Equity Ratio for Q1 2026 stood at 32.71, down from 7.06 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.0 in Q3 2022 and bottomed at 63.28 in Q2 2025.
- The 5-year median for Equity Ratio is 7.99 (2025), against an average of 15.42.
- The widest annual swing landed in 2022, when Equity Ratio surged 89.61%; it then slumped 317575.9% in 2023.
- A 5-year view of Equity Ratio shows it stood at 0.0 in 2022, then plunged by 317575.9% to 10.11 in 2023, then sank by 283.86% to 38.79 in 2024, then jumped by 81.8% to 7.06 in 2025, then slumped by 363.23% to 32.71 in 2026.
- The last three Equity Ratio figures came in at 32.71 (Q1 2026), 7.06 (Q4 2025), and 7.99 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Profusa | - | - | - | -32.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.71 |
| Dec 31, 2025 | -7.06 |
| Sep 30, 2025 | -7.99 |
| Jun 30, 2025 | -63.28 |
| Mar 31, 2025 | -61.46 |
| Dec 31, 2024 | -38.79 |
| Sep 30, 2024 | -13.32 |
| Jun 30, 2024 | -13.33 |
| Mar 31, 2024 | -13.18 |
| Dec 31, 2023 | -10.11 |
| Sep 30, 2023 | -0.32 |
| Jun 30, 2023 | -0.26 |
| Mar 31, 2023 | -0.31 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.03 |